切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2017, Vol. 05 ›› Issue (04) : 225 -229. doi: 10.3877/cma.j.issn.2095-655X.2017.04.003

所属专题: 文献

心脑血管疾病诊治

新疆维吾尔族、哈萨克族高血压患者血管紧张素转换酶基因I/D多态性与血管紧张素转化酶抑制剂降压疗效的关系
谷兰平1, 徐新娟1,(), 张荣秀1   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院高血压科
  • 收稿日期:2017-08-28 出版日期:2017-11-26
  • 通信作者: 徐新娟
  • 基金资助:
    新疆维吾尔自治区科技支撑计划(201533104)

Relationship between angiotensin-converting enzyme gene I/D polymorphism and antihypertensive efficacy of ACE inhibitors in hypertensive patients of Uyghur and Kazak in Xinjiang

Lanping Gu1, Xinjuan Xu1,(), Rongxiu Zhang1   

  1. 1. Department of Hypertension, the first Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • Received:2017-08-28 Published:2017-11-26
  • Corresponding author: Xinjuan Xu
  • About author:
    Corresponding author: Xu Xinjuan, Email:
引用本文:

谷兰平, 徐新娟, 张荣秀. 新疆维吾尔族、哈萨克族高血压患者血管紧张素转换酶基因I/D多态性与血管紧张素转化酶抑制剂降压疗效的关系[J/OL]. 中华诊断学电子杂志, 2017, 05(04): 225-229.

Lanping Gu, Xinjuan Xu, Rongxiu Zhang. Relationship between angiotensin-converting enzyme gene I/D polymorphism and antihypertensive efficacy of ACE inhibitors in hypertensive patients of Uyghur and Kazak in Xinjiang[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2017, 05(04): 225-229.

目的

探讨血管紧张素转换酶(ACE)基因I/D多态性,在新疆维吾尔族、哈萨克族原发性高血压患者的差异与血管紧张素转换酶抑制剂(ACEI)降压疗效的关系。

方法

选取2015年11月至2017年4月于新疆医科大学第一附属医院高血压科就诊的394例原发性高血压患者,其中维吾尔族191例,哈萨克族203例。采用基因多态性检测试剂盒(PCR-荧光探针技术)对ACE I/D基因型等进行检测,对两组降压疗效、不良反应进行分析。统计学处理采用SPSS 17.0处理,相关危险因素采用非条件Logistic回归分析。

结果

394例三种基因型患者对ACEI类药物疗效正常敏感性、高敏感性例数分别为137,257例,频率为34.77%、65.23%。其中维吾尔族分别为33.51%(64/191)、66.49%(127/191),哈萨克族分别为35.96%(73/203)、64.04%(130/203),两民族的ACE I/D基因多态性与ACEI类药物疗效差异无统计学意义(χ2=0.26,P>0.05)。394例三种基因型患者对ACEI类药物不良反应明显增加的例数为81例,频率为20.56%,其中维吾尔族患者为19.37%(37/191),哈萨克族患者为21.67%(44/203),两民族对ACEI类药物不良反应差异无统计学意义(χ2=0.32,P>0.05)。非条件Logistic回归分析显示,ACE I/D的民族差异与ACEI类药物疗效无相关性(OR=0.69,P>0.05)。

结论

ACE I/D基因多态性在新疆哈萨克族、维吾尔族原发性高血压患者的民族差异与ACEI类药物疗效无相关性。

Objective

To investigate the correlation between the angiotensin-converting enzyme(ACE) gene I/D polymorphism and prospective antihypertensive efficacy of ACE inhibitors (ACEI) in Xinjiang, Kazak, Uyghur patients with essential hypertension.

Methods

From November 2015 to April 2017, 394 patients with primary hypertension in the first Affiliated Hospital of Xinjiang Medical University were enrolled, including 191 Uyghur cases, 203 Kazak cases.The efficacy of ACE I/D genotype, ACEI drug efficacy, and adverse events were detected by the Gene Polymorphism Test Kit (PCR-fluorescence Probe Technique). The antihypertensive efficacy and adverse reactions of ACEI were analyzed.

Results

Among the 394 patients, the number of normal sensitivity and high sensitivity to ACEI were 137 and 257 respectively.The frequency were 34.77%and 65.23%.Uyghur nationality were 33.51%(64/191) and 66.49%(127/191), Kazak patients were 35.96%(73/203) and 64.04%(130/203), respectively.There was no significant difference between the two groups(χ2=0.26, P>0.05). In 394 patients, the number of adverse drug reactions to ACEI was 81, and the frequency significantly increased by 20.56%, of which 19.37%(37/191) in Kazak and 21.67%(44/203) in Uyghur.There was no significant difference between the two nationalities in the adverse reactions of ACEI (χ2=0.32, P>0.05). Logistic regression analysis showed that ethnic differences in ACE I/D had no association with the efficacy of ACEI (OR=0.69, P>0.05).

Conclusion

There is no correlation between ACE gene I/D polymorphism in Xinjiang Kazak and Uygur patients with essential hypertension and the curative effect of ACEI.

表1 两组患者基线资料比较(±s)
表2 两组原发性高血压患者Hardy-Weinberg平衡检验的比较(例,%)
表3 两组原发性高血压患者对ACEI类降压药物疗效的比较(例,%)
表4 两组原发性高血压患者对ACEI类药物的不良反应的比较(例,%)
表5 两组原发性高血压患者对ACEI药物疗效相关因素的Logisitc回归结果
[1]
Correa-Noronha SA,Noronha SM,Alecrim C, et al.Association of angiotensin-converting enzyme I gene I/D polymorphism with endometrial but not with ovarian cancer[J]. Gynecol Endocrinol, 2012, 28(11): 889-891.
[2]
徐新献,姚武位,周婧, 等. 不同年龄段老年高血压病患者动态血压及血压昼夜节律的变化特征[J/CD]. 中华诊断学电子杂志, 2016, 4(1): 56-58.
[3]
高珺,刘必成,王艳丽, 等. 卡托普利对白蛋白引起HK-2细胞ACE/ACE2表达的影响[J]. 现代医学, 2008, 36(4): 231-235.
[4]
Zarouk WA,Hussein IR,Esmaeil NN, et al.Association of angiotensin converting enzyme gene(I/D)polymorphism with hypertension and type 2 diabetes[J]. Bratisl Lek Listy, 2012, 113(1): 14-18.
[5]
Luo W,Guo Z,Hao C, et al.Interaction of current alcohol consumption and abdominal obesity on hypertension risk[J]. Physiol Behav, 2013, 122: 182-186.
[6]
Das S,Roy S,Sharma V, et al.Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke:comparison with ischemic stroke[J]. Neurol Sci, 2015, 36(1): 137-142.
[7]
Ji LD,Zhang LN,Shen P, et al.Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population:a meta-analysis[J]. J Hypertens, 2010, 28(3): 419-428.
[8]
中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011 , 19(8) : 701-743.
[9]
Fox KM.Efficacy of perindopril in reduction of cardiovascular events among patients with stable corunary artery disease:randomised, double blind, placebo controlled, multicentre trial[J]. Lancet, 2003, 362(9386): 782-788.
[10]
Hernández OE,Medina FA,Rodríguez Esparragón FJ, et al.[The involvement of the renin-angiotensin system gene polymorphisms in coronary heart disease][J]. ReV Esp Cardiol, 2002, 55(2): 92-99.
[11]
Puthucheary Z,Skipworth JR,Rawal J, et al.The ACE gene and human performance:12 years on[J]. Sports Med, 2011, 41(6): 433-448.
[12]
艾力曼·马合木提,迪力努尔,卡丽比努尔, 等. 新疆维吾尔族ACE基因I/D多态性分析及其血清ACE水平的相关性[J]. 山西医科大学学报, 2003, 34(5): 405-407.
[13]
陈才伟,刘大男. CYP11B2-344T/C、ACE I/D基因多态性与贵州苗族、汉族原发性高血压患者血清PIIINT、MMP-9、hs-CRP的相关性[J]. 贵阳医学院, 2015.28(10): 32-34.
[14]
张丽萍,戴庆,陈慧锦, 等. 新疆维吾尔族原发性高血压与ACE基因I/D多态性的相关性研究[J]. 新疆医科大学学报, 2012, 35(8): 1008-1012.
[15]
孙艳,李娟,孟祥冬, 等. 青壮年原发性高血压患者血清中ACE、AngII水平ACE基因多态性之间的相关性分析[J]. 医学信息, 2016, 29(17): 74-75.
[16]
梁冰,胡丙清,刘绪和,老年高血压患者ACEI/D基因多态性与ACE抑制剂疗效的相关性[J], 齐齐哈尔医学院学报, 2014, 35(20): 2969-2971.
[17]
李菁,孙宁玲. 原发性高血压与血管紧张素转换酶基因I/D多态性的研究[J]. 中日友好医院学报, 2005, 19(1): 19-21.
[18]
van der Kleij FG,de Jong PE,Henning RH, et al.Enhanced responses of blood pressure, renal function and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake[J]. J Am Soc Nephrol, 2002, 13(4): 1025-1033.
[19]
Schelleman H,Klungel OH,van Duijn CM, et al. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy[J]. Ann Phamacother, 2006, 40(2): 212-218.
[20]
Agerholm-Larsen B,Nordestgaard BG,Tybjaerg-Hansen A, et al, ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in Whites[J]. Arterioscler Thromb Vasc Biol, 2000, 20(2): 484-492.
[21]
Furuya K,Yamaquchi E,Hirbyashi T, et al.Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough[J]. Lancet, 1994, 343(8893): 354.
[22]
乔崇,李玉东,刘志远, 等. 南阳地区高血压人群基因多态性与抗高血压药物个体差异性关系临床研究[J]. 中国医药科学, 2013, 3(24): 10-12, 28.
[1] 张启龙, 柳亿, 卢会丽, 罗慧, 李成林, 王菁, 王辉. 奥妥珠单抗治疗磷脂酶A2受体相关膜性肾病的疗效与安全性:单中心回顾性分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 379-384.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 聂生军, 王钰, 王毅, 鲜小庆, 马生成. 复方倍他米松局部注射联合光动力疗法治疗小型瘢痕疙瘩的临床疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 404-410.
[4] 莫淇舟, 苏劲, 黄健, 李健维, 李思宁, 柳建军. 智能控压输尿管软镜碎石吸引取石术在直径10~25 mm上尿路结石中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 497-502.
[5] 李义亮, 苏拉依曼·牙库甫, 麦麦提艾力·麦麦提明, 克力木·阿不都热依木. 机器人与腹腔镜食管裂孔疝修补术联合Nissen 胃底折叠术短期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 512-517.
[6] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[7] 王亚岚, 倪婧, 余世庆, 陶银花, 张荣. 尼达尼布抗纤维化治疗特发性肺纤维化的耐受性和疗效预测因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 750-755.
[8] 詹济玮, 蔡柳春, 温琼娜, 郭石生, 温春妹, 温鹤明. 布地格福联合噻托溴铵治疗AECOPD 的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 823-826.
[9] 魏孔源, 仵正, 王铮, 黎韡. 机器人胰腺中段切除后远端胰腺消化道不同重建方式初探[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 295-300.
[10] 梁艳娉, 列诗韵, 王艺穗, 吴晓瑛, 林颖. 基于内镜操作细节记录系统构建胃底静脉曲张内镜下组织胶注射术的标准化管理方案[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 705-709.
[11] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[12] 史彬, 司远. 益气和络方联合缬沙坦治疗气阴两虚兼血瘀证IgA 肾病的疗效观察[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 306-312.
[13] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
[14] 阳跃, 庹晓晔, 崔子豪, 欧阳四民, 林海阳, 胡景宇, 胡银, 李涛, 赵景峰, 郝岱峰, 冯光. 改良“阅读者”皮瓣修复骶尾部压疮的疗效[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 751-755.
[15] 克地尔牙·马合木提, 胡波, 杨琼, 闫素, 胡岚卿, 高沛沛, 姚恩生. 依达拉奉右莰醇对急性脑梗死后认知功能障碍的疗效观察[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 459-466.
阅读次数
全文


摘要